Position in LLY
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$227,569,072
+$66,551,377 QoQ
Shares Held
189,731
+8.4% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#247
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2025CallValue
$89,676,351
CallShares
115,039
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $931,707,784 across 15 Drug Manufacturers - General names. LLY ranks #2 (24.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
931,576 | $236,592,356 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
189,731 | $227,569,072 | |
| 3 | ABBV |
AbbVie Inc.
|
543,313 | $136,719,283 | |
| 4 | MRK |
Merck & Co., Inc.
|
845,459 | $108,641,481 | |
| 5 | AMGN |
Amgen Inc
|
145,549 | $52,706,203 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
309,147 | $39,057,631 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
636,124 | $36,653,464 | |
| 8 | PFE |
Pfizer Inc
|
1,165,477 | $28,064,686 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $227,569,072 | 189,731 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $161,017,695 | 175,063 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $144,426,258 | 134,390 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $96,519,500 | 126,500 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $89,676,351 | 115,039 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $92,762,081 | 112,315 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $86,142,848 | 111,584 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $622,668,753 | 702,834 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $628,388,042 | 694,060 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $537,865,206 | 691,379 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $407,745,544 | 699,488 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $54,815,190 | 102,052 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $49,500,838 | 105,550 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $30,260,796 | 88,116 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $31,463,703 | 86,004 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $25,037,313 | 77,431 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $24,831,154 | 76,585 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $19,932,783 | 69,605 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $17,094,979 | 61,889 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $14,103,754 | 61,042 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $14,551,108 | 63,398 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $9,658,594 | 51,700 | Shares | Sole | 2021-08-10 | |
| 2020-12-31 | $7,923,154 | 46,927 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,283,745 | 42,452 | Shares | Sole | 2020-12-10 | |
| 2020-06-30 | $6,346,213 | 38,654 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $5,122,513 | 36,927 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||